Compile Data Set for Download or QSAR
maximum 50k data
Found 85 with Last Name = 'tang' and Initial = 'pc'
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109275(US8609622, 2)
Affinity DataIC50:  1.42nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109278(US8609622, 5)
Affinity DataIC50:  1.49nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139994(US8901140, 9 | US9358227, 9)
Affinity DataIC50:  2nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139993(US8901140, 8 | US9358227, 8)
Affinity DataIC50:  2nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209856(US9273052, 15 | US9566277, 15)
Affinity DataIC50:  2.30nMT: 2°CAssay Description:he assay described below is to determine the activity of the compounds of the present invention for inhibiting the enzyme activity of PARP by using t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209856(US9273052, 15 | US9566277, 15)
Affinity DataIC50:  2.30nMT: 2°CAssay Description:The tested compounds were dissolved in dimethylsulfoxide and then diluted with 1x buffer to the concentration desired in the experiment. 25 uL of a 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM5445(CHEMBL554 | GW572016 | LAPATINIB DITOSYLATE | Lapa...)
Affinity DataIC50:  3nMAssay Description:Inhibition of HER2 by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50:  3.31nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109275(US8609622, 2)
Affinity DataIC50:  3.65nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139992(US8901140, 7 | US9358227, 7)
Affinity DataIC50:  4nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50311465(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-me...)
Affinity DataIC50:  4nMAssay Description:Inhibition of HER2 by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109279(US8609622, 7)
Affinity DataIC50:  4.58nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209854(US9273052, 2 | US9566277, 2)
Affinity DataIC50:  5nMT: 2°CAssay Description:he assay described below is to determine the activity of the compounds of the present invention for inhibiting the enzyme activity of PARP by using t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209854(US9273052, 2 | US9566277, 2)
Affinity DataIC50:  5nMT: 2°CAssay Description:The tested compounds were dissolved in dimethylsulfoxide and then diluted with 1x buffer to the concentration desired in the experiment. 25 uL of a 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139989(US8901140, 2 | US9358227, 2)
Affinity DataIC50:  6nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50:  6.35nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50:  6.92nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50311462(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2...)
Affinity DataIC50:  7nMAssay Description:Inhibition of HER2 by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109276(US8609622, 3)
Affinity DataIC50:  8.08nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109280(US8609622, 9)
Affinity DataIC50:  9.28nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 2(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109274(US8609622, 1)
Affinity DataIC50:  9.53nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209857(US9273052, 19 | US9566277, 19)
Affinity DataIC50:  10.2nMT: 2°CAssay Description:The tested compounds were dissolved in dimethylsulfoxide and then diluted with 1x buffer to the concentration desired in the experiment. 25 uL of a 2...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209857(US9273052, 19 | US9566277, 19)
Affinity DataIC50:  10.2nMT: 2°CAssay Description:he assay described below is to determine the activity of the compounds of the present invention for inhibiting the enzyme activity of PARP by using t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139991(US8901140, 5 | US9358227, 5)
Affinity DataIC50:  13nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209853(US9273052, 1 | US9566277, 1)
Affinity DataIC50:  15nMT: 2°CAssay Description:he assay described below is to determine the activity of the compounds of the present invention for inhibiting the enzyme activity of PARP by using t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209853(US9273052, 1 | US9566277, 1)
Affinity DataIC50:  15nMT: 2°CAssay Description:The tested compounds were dissolved in dimethylsulfoxide and then diluted with 1x buffer to the concentration desired in the experiment. 25 uL of a 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM5446(CHEMBL553 | ERLOTINIB HYDROCHLORIDE | Erlotinib | ...)
Affinity DataIC50:  15nMAssay Description:Inhibition of EGFR by HTRF assayMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM5445(CHEMBL554 | GW572016 | LAPATINIB DITOSYLATE | Lapa...)
Affinity DataIC50:  19nMAssay Description:Inhibition of EGFR by HTRF assayMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139988(US8901140, 1 | US9358227, 1)
Affinity DataIC50:  48nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209855(US9273052, 3 | US9566277, 3)
Affinity DataIC50:  52nMT: 2°CAssay Description:The tested compounds were dissolved in dimethylsulfoxide and then diluted with 1x buffer to the concentration desired in the experiment. 25 uL of a 2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical

US Patent
LigandPNGBDBM209855(US9273052, 3 | US9566277, 3)
Affinity DataIC50:  52nMT: 2°CAssay Description:he assay described below is to determine the activity of the compounds of the present invention for inhibiting the enzyme activity of PARP by using t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139990(US8901140, 3 | US9358227, 3)
Affinity DataIC50:  59nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM5445(CHEMBL554 | GW572016 | LAPATINIB DITOSYLATE | Lapa...)
Affinity DataIC50:  124nMAssay Description:Inhibition of HER2 in human SKBR3 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM5445(CHEMBL554 | GW572016 | LAPATINIB DITOSYLATE | Lapa...)
Affinity DataIC50:  140nMAssay Description:Inhibition of EGFR in human A431 cells by HTRF assayMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50311464(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-me...)
Affinity DataIC50:  257nMAssay Description:Inhibition of EGFR in human A431 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM5446(CHEMBL553 | ERLOTINIB HYDROCHLORIDE | Erlotinib | ...)
Affinity DataIC50:  420nMAssay Description:Inhibition of EGFR in human A431 cells by HTRF assayMore data for this Ligand-Target Pair
TargetSGLT1 protein(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109275(US8609622, 2)
Affinity DataIC50:  600nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50311469(7-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2...)
Affinity DataIC50:  620nMAssay Description:Inhibition of HER2 in human SKBR3 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50311464(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-me...)
Affinity DataIC50:  843nMAssay Description:Inhibition of HER2 in human SKBR3 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50311466(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-...)
Affinity DataIC50:  867nMAssay Description:Inhibition of EGFR in human A431 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50311467(CHEMBL1080990 | ethyl 4-(3-chloro-4-(3-fluorobenzy...)
Affinity DataIC50:  934nMAssay Description:Inhibition of HER2 in human SKBR3 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50311462(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2...)
Affinity DataIC50:  960nMAssay Description:Inhibition of HER2 in human SKBR3 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50311463(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-me...)
Affinity DataIC50:  980nMAssay Description:Inhibition of EGFR in human A431 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50311462(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2...)
Affinity DataIC50:  1.16E+3nMAssay Description:Inhibition of EGFR in human A431 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50311467(CHEMBL1080990 | ethyl 4-(3-chloro-4-(3-fluorobenzy...)
Affinity DataIC50:  1.21E+3nMAssay Description:Inhibition of EGFR in human A431 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSGLT1 protein(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50:  1.22E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSGLT1 protein(Mus musculus (Mouse))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109280(US8609622, 9)
Affinity DataIC50:  1.26E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50311462(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2...)
Affinity DataIC50:  1.28E+3nMAssay Description:Inhibition of EGFR by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM5446(CHEMBL553 | ERLOTINIB HYDROCHLORIDE | Erlotinib | ...)
Affinity DataIC50:  1.52E+3nMAssay Description:Inhibition of HER2 by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Shanghai Hengrui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM5446(CHEMBL553 | ERLOTINIB HYDROCHLORIDE | Erlotinib | ...)
Affinity DataIC50:  1.89E+3nMAssay Description:Inhibition of HER2 in human SKBR3 cells by HTRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: